| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.409 | 20.830 | 18.006 | 20.756 | 21.536 | 17.972 | 29.889 | 40.909 | 26.605 | 67.548 |
| Total Income - EUR | 39.409 | 21.609 | 18.006 | 20.756 | 21.711 | 18.146 | 29.889 | 40.909 | 26.605 | 67.548 |
| Total Expenses - EUR | 23.085 | 37.405 | 18.159 | 18.496 | 28.380 | 25.739 | 35.934 | 22.622 | 29.381 | 35.160 |
| Gross Profit/Loss - EUR | 16.324 | -15.796 | -153 | 2.260 | -6.669 | -7.593 | -6.045 | 18.286 | -2.776 | 32.388 |
| Net Profit/Loss - EUR | 15.121 | -16.420 | -694 | 1.637 | -7.321 | -8.138 | -6.949 | 17.083 | -3.042 | 31.323 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medart Global Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 687 | 10.345 | 10.170 | 11.749 | 28.662 | 20.243 | 12.419 | 7.203 | 4.258 | 4.928 |
| Current Assets | 51.106 | 19.079 | 21.239 | 23.037 | 8.727 | 6.914 | 8.109 | 27.693 | 10.016 | 36.449 |
| Inventories | 8.648 | 6.944 | 3.730 | 3.661 | 3.515 | 3.448 | 887 | 2.304 | 887 | 883 |
| Receivables | 14.854 | 3.903 | 6.326 | 7.870 | -50 | 222 | 6.390 | 0 | 1.280 | 20.403 |
| Cash | 27.603 | 8.231 | 11.184 | 11.506 | 5.262 | 3.244 | 832 | 25.389 | 7.848 | 15.163 |
| Shareholders Funds | 45.456 | 28.572 | 27.395 | 28.530 | 20.657 | 12.128 | 4.910 | 22.008 | 4.344 | 31.371 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.337 | 851 | 4.013 | 6.257 | 16.732 | 15.029 | 15.618 | 12.888 | 9.930 | 10.005 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Medart Global Srl